Blood Group O Linked to Longer Survival in MGMT-Methylated Glioblastoma Patients
A retrospective study at University Hospital Bonn independently confirms that blood group O is associated with significantly longer progression-free and ...
A retrospective study at University Hospital Bonn independently confirms that blood group O is associated with significantly longer progression-free and ...
A retrospective real-world study found that neoadjuvant chemoimmunotherapy followed by surgery produced significantly longer overall survival and strong pathologic responses ...
A Brazilian study of 53 myeloma patients with renal impairment shows autologous stem cell transplantation carries high toxicity and intensive ...
Navigated transcranial magnetic stimulation before surgery revealed that cortical excitability scores independently predict overall survival in patients with motor-eloquent glioblastoma.
A new meta-analysis of nearly 12,000 patients links early-day immune checkpoint inhibitor infusions with markedly better survival in advanced solid ...
A national cohort study of 1,112 Austrian AML patients spanning 2000 to 2017 shows gradual improvements in five-year survival after ...
A new analysis shows that post-progression censoring may have generated a misleading survival advantage for nivolumab in second-line mesothelioma, resolving ...
A prospective Phase II trial in Japan found that biweekly gemcitabine plus nab-paclitaxel produced a 47.1 percent response rate and ...
A study of more than 5,000 US patients with HR-positive/HER2-negative metastatic breast cancer found median survival of only 13.5 months ...
A nationwide Turkish cohort study of 53 children with Down syndrome shows that those with Down syndrome-related myeloid leukemia achieved ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine